- cafead   Feb 10, 2025 at 10:32: AM
via Kineta has found a new home for deals with Genentech and Merck & Co. Tidying up the portfolio ahead of its merger with TuHURA Biosciences, the biotech has agreed to sell the deals to an investment firm, offload a pain prospect to Pacira Pharmaceuticals and scrap its pact with GigaGen.
article source
article source